ACORDA THERAPEUTICS (ACOR): TIME TO TAKE PROFITS

It is time to take profits on Acorda Therapeutics (ACOR).   Consider  taking profits on the entire position of Acorda Therapeutics right here at $23.08. Ampyra, the drug that has caused most excitement  in Acora  Therapeutics, is not proving to be a very good drug as we had predicted.  

Read More

BROADCOM (BRCM) BUYS NETLOGIC (NETL)

Broadcom (BRCM) is acquiring  NetLogic  (NETL) for approximately $3.7 billion.   NetLogic share holders will receive $50 per share.   Broadcom expects the acquisition to be accretive by approximately $1.10.   Broadcom also reaffirmed its business outlook for Q3. Those holding NetLogic may consider continuing to hold it until the

Read More

9 Winners. 9 Losers. Gold, Silver & AI Trade Zones.

9 Winners. 9 Losers.
Gold, Silver & AI Trade Zones.

A new market cycle is forming.

AI, Metals &
Memory Playbook

See where sophisticated investors are positioning across software, precious metals, and AI memory.

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

Skip to content